Skip to main content

Page last checked

Growth hormone-releasing hormone fragment (compounded preparation) · safety

Sermorelin side effects

The sermorelin side effects reported most often are anti-GHRH antibodies, rise in serum phosphate and injection-site pain. The full list is below, with the cited trial report cited at the bottom of the page.

Rarer, but worth being able to spot: allergic reaction and unknown long-term risk.

The sources describe these effects in relation to the dose and to the early weeks.

Sermorelin is the first 29 amino acids of the hormone that prompts growth hormone release. It is the shortest piece that still does the job at the pituitary. Anti-aging and wellness clinics sell it for energy, body composition and sleep.

None of that is what it was approved for. As Geref it was an American medicine for testing pituitary function and for growth failure in children. That product was withdrawn. The one adult study on this page ran 14 days and measured hormone levels, not how anyone looked or felt.

Further down: the full list with frequencies · when to get medical help · questions

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewerReviewed 2026-08-12open the primary sources

At a glance

Common reactions listed

5

Serious reactions listed

2

Boxed warning

No label exists

Strongest source

limited human data

The counts show how many distinct reactions the cited trial report names. The percentages show how often a reaction appeared in a study group, not the chance that it will happen to you.

Common reactions

The full list, as reported across the available trial evidence. There is no approved label to read frequency bands off, so these are the trials’ own figures.

Common reactionstrial-reported
ReactionFrequency
Anti-GHRH antibodiesDetected in 4 of 11 treated children at six months and 6 of 11 at twelve months; growth continued in the children who developed them
Rise in serum phosphateSignificant over 14 days of twice-daily dosing in older men, while fasting glucose, urinary C-peptide, blood pressure and blood counts were unchanged
Injection-site painNamed in the review literature as a reported reaction; no incidence figure has been published for it
Short-term flushing, nausea, dizziness and headacheNamed in the review literature as reported reactions; no incidence figure has been published for them
Transient prolactin riseDescribed in the review literature as small and rapid; no incidence figure has been published

Serious reactions to watch for

These are rarer, and they are the ones clinicians monitor for. Seek medical care if you have symptoms.

Serious — monitorwarning/precaution
ReactionFrequency
Allergic reactionDescribed as rare in the review literature — monitor
Unknown long-term riskNo long-term safety data exists. The pediatric trials ran a year, the adult study 14 days, and nothing longer has been published — monitor

limited human dataEvery reaction above comes from a cited trial. These are study findings, not instructions on what to take.

When to seek medical care

Each one below is a serious reaction from the table above, written as the signs you would actually notice. Spotting them is the job of this section; working out what they mean is a clinician’s.

Severe hypersensitivity reaction

Urgent

Signs: Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, a rash or hives spreading fast, or suddenly feeling faint.

This is the one on the list that does not wait. Call emergency services immediately rather than a clinic.

EmergencySome symptoms should not wait for an appointment. Call emergency services (911 in the US) if they are severe, getting worse fast, or involve trouble breathing, chest pain, fainting or confusion.

1Read deeperTiming, evidence limits, and product context

When these effects tend to occur

The cited evidence describes these effects in relation to the dose and to the early period of taking it, rather than as a constant background throughout.

When a study reports how side effects changed over time, it describes the group as a whole. It cannot predict one person’s experience.

Common questions

How long do sermorelin side effects last, and do they go away?

The sources do not commit to a set number of days. What they describe is a pattern — reactions cluster after you start and after each increase, then ease while the dose is held steady. Any page quoting an exact number of days is quoting something the sources do not say.

What are the most common sermorelin side effects?

Anti-GHRH antibodies, rise in serum phosphate, injection-site pain and short-term flushing, nausea, dizziness and headache — the table above has the rest, each with its frequency band and source.

Does sermorelin have a boxed warning?

No, because a boxed warning is part of an FDA-approved label and sermorelin has no approved label. That reflects what regulatory review has and has not covered, not a finding that serious risks were looked for and ruled out.

Can the sermorelin dose be lowered if side effects are hard to tolerate?

That decision belongs to the prescribing clinician. No approved schedule exists for this compound, so there is no labeled framework for adjusting a dose. That leaves the prescriber as the only place the decision can sit.

Does sermorelin cause hair loss?

Hair loss is not among the reactions listed on this page for sermorelin, because the cited trial report cited here does not carry it. Anything missing from the tables is outside what can be sourced here rather than ruled out, and a symptom that worries you belongs with a clinician.

Is fatigue a listed sermorelin side effect?

No — the cited trial report cited here does not list it. That describes what was reported, not proof that the symptom cannot happen.

Is constipation a listed sermorelin side effect?

Not separately. If a source groups stomach and gut events together, this page keeps that group intact. It does not invent named reactions the source never listed.

What should someone do about a serious sermorelin reaction?

Contact a clinician promptly, and emergency services if symptoms are severe or getting worse quickly. The section above describes what those reactions actually look like, so they can be spotted early rather than explained away.

Do the frequencies on this page mean the chance it happens to one person?

No. These figures describe groups in a study. A band shows how often a reaction appeared under that trial’s conditions. It cannot predict what will happen to one person.

Related

The schedule these reactions were recorded against, the comparisons, and the sourcing rules behind every grade on this page.

Questions readers ask

Is it safe to take sermorelin?

The published research cannot answer that, because the longest study lasted a year and ran in children. FDA did rule that the branded product left the market for business reasons rather than safety ones. That ruling covers the old product, not what a pharmacy or a research seller ships today.

In the older men, blood sugar, blood pressure and blood counts held steady across two weeks. Serum phosphate rose. Two weeks is far too short to catch anything slower than that.

What does sermorelin do to your face?

Nothing published describes an effect on the face beyond short-term flushing. Review literature names flushing among the reported reactions and gives no figure for how often it happens. No trial has measured skin, wrinkles or facial shape.

The anti-aging look is what sellers point at. It is not what the trials looked at — those measured hormone levels in blood and, in the children, height.

What to avoid while taking sermorelin?

Nobody has published a list of things to avoid. A label is where such a list lives, and this peptide lost its label when the approval ended in 2009. The trials screened their participants, watched them, and reported nothing about food, alcohol or other medicines.

That gap is not a clean bill. It means the checking that produces such a list never happened here.

How long can you stay on sermorelin?

No published study ran past a year, so no evidence covers any longer stretch. The children’s trials lasted twelve months. The adult study lasted fourteen days.

The page flags unknown long-term risk on exactly that basis. How long anyone stays on it is a call for the clinician prescribing it, made on evidence this thin.

3primary sources, each with the day we read it — open the documents used on this page